Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: inhalation
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
other information
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Referenced source in an international report.

Data source

Reference
Reference Type:
review article or handbook
Title:
Dimethylformamide, SIDS Initial Assessment Report For SIAM 13
Author:
OECD
Year:
2001
Bibliographic source:
UNEP publications

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
No further details
GLP compliance:
no
Test type:
standard acute method

Test material

Constituent 1
Chemical structure
Reference substance name:
N,N-dimethylformamide
EC Number:
200-679-5
EC Name:
N,N-dimethylformamide
Cas Number:
68-12-2
Molecular formula:
C3H7NO
IUPAC Name:
N,N-dimethylformamide
Details on test material:
purity: 99.7%

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female

Administration / exposure

Route of administration:
inhalation: vapour
Type of inhalation exposure:
whole body
Vehicle:
not specified
Analytical verification of test atmosphere concentrations:
yes
Duration of exposure:
4 h
Concentrations:
2.23, 4.92, 5.10 and 5.85 mg/L
No. of animals per sex per dose:
10 animals per sex per dose
Control animals:
yes
Details on study design:
After the 4 h DMF-exposure, the animals were examined for 14 days. Body weight was determined before the beginning of the study, after 7 days during the study and at the end of the post observation period. The animals were daily observed for clinical signs and mortality. Animals that died during the study and the
surviving animals sacrificed at the end of the post observation period were necropsied and macroscopically examined.

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LC50
Effect level:
> 5.85 mg/L air (analytical)
Based on:
not specified
Exp. duration:
4 h
Mortality:
Deaths occurred 3 days after the start of the study; at 4.92 mg/l 2 of 10 males and 1 of 10 females died, at 5.1 mg/l all animals survived treatment and at 5.85 mg/l 3 of 10 males and no female animal died.
Clinical signs:
other: At the analytical concentration of 2.23 mg/L all animals survived and did not show any clinical signs related to DMF exposure. In the other three treatment groups dyspnoea (irregular or intermittent respiration) and rough fur were observed as well as in 3
Gross pathology:
Surviving animals recovered 6-7 days after exposure. These animals did not show any gross lesions at necropsy, whereas the animals that died during the study had some organ findings, e.g. discoloration of the liver, hemorrhage in thymus and punctate hemorrhage in pancreas and in the gastric mucous membrane.

Applicant's summary and conclusion

Conclusions:
The LC50 by inhalation route for an exposure duration of 4h was found > 5.85 mg/L for male and female rats.